Omnicell, Inc. $125 Million SEC-Registered At-The-Market Offering

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Omnicell, Inc. of its shares of common stock for up to an aggregate amount of $125 million.

Omnicell, Inc. is a provider of comprehensive automation and business analytics software solutions for patient-centric medication and supply management.

The Davis Polk capital markets team included partner Michael Kaplan and associates Ferrell Maguire Keel and Jenny J. Choi. Partner Frank J. Azzopardi and associate Christopher C. Woller provided intellectual property and technology advice. Partner Rachel D. Kleinberg and associate Joshua J. Micelotta provided tax advice. Members of the Davis Polk team are based in the New York and Northern California offices.